News from the healthcare data industry
Steven Loeb speaks with Miruna Sasu, President and CEO of COTA, a company that combines oncology expertise with technology and analytics to organize real world data in order to guide decisions...
New clinical workflow software aims to solve timing challenges in neurovascular emergencies for the entire care team CAMBRIDGE, Mass., Oct. 5, 2022 /PRNewswire/ — ConcertAI’s TeraRecon, the leading AI and advanced visualization platform...
The first Fully Digital, Clinical Trial Solution for Oncology, Hematology & Urology CAMBRIDGE, Mass., Sept. 29, 2022 /PRNewswire/ — ConcertAI, LLC (ConcertAI) announced the launch of its new Digital Trial Software-as-a-Service solution. Powered...
Collaboration Utilizes RWD-enabled Capabilities Across Hospitals and Research Organizations to Transform the Elimination of Disparities NEW ORLEANS and CAMBRIDGE, Mass., Sept. 27, 2022 /PRNewswire/ — The National Cancer Institute Community Oncology Research Program (NCI...
Global product launch reinforces the company’s market and innovation leadership in subscription-based Advanced Visualization (AV) solutions to advance clinical care CAMBRIDGE, Mass., July 15, 2022 /PRNewswire/ — TeraRecon, a ConcertAI company and...
DURHAM, N.C., July 13, 2022 /PRNewswire/ — TeraRecon, a ConcertAI company and a leader in advanced medical visualization using AI to improve patient care, today announced U.S.-based DocPanel, the world’s first radiology marketplace...
April 05, 2022 07:00 AM Eastern Daylight Time WASHINGTON–(BUSINESS WIRE)–The RWE Alliance is pleased to announce the addition of five new members—ConcertAI, OM1, Syneos Health, Verana Health, and Verily—to continue to advance policies to support regulatory...
ConcertAI SaaS and data solutions have rapidly emerged as the industry standard for accelerating clinical trials and patient outcomes CAMBRIDGE, Mass., March 29, 2022 /PRNewswire/ — ConcertAI, LLC (ConcertAI), the leader in enterprise...
An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking. Read more: HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2022/03/14/PHARMA-LEADERS-SHOULD-STEP-UP-ON-ARTIFICIAL-INTELLIGENCE-CONCERTAI
An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking. Read more: HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2022/03/14/PHARMA-LEADERS-SHOULD-STEP-UP-ON-ARTIFICIAL-INTELLIGENCE-CONCERTAI